- Home
- EDSA vs LDTC Comparison
EDSA vs LDTC Comparison
Compare EDSA & LDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDSA
- LDTC
- Stock Information
- Founded
- EDSA 2015
- LDTC 2007
- Country
- EDSA Canada
- LDTC Canada
- Employees
- EDSA N/A
- LDTC 150
- Industry
- EDSA Biotechnology: Pharmaceutical Preparations
- LDTC Blank Checks
- Sector
- EDSA Health Care
- LDTC Finance
- Exchange
- EDSA Nasdaq
- LDTC Nasdaq
- Market Cap
- EDSA 11.0M
- LDTC 9.4M
- IPO Year
- EDSA N/A
- LDTC N/A
- Fundamental
- Price
- EDSA $2.09
- LDTC $0.32
- Analyst Decision
- EDSA Strong Buy
- LDTC Buy
- Analyst Count
- EDSA 1
- LDTC 3
- Target Price
- EDSA $21.00
- LDTC $1.00
- AVG Volume (30 Days)
- EDSA 50.3K
- LDTC 157.8K
- Earning Date
- EDSA 12-13-2024
- LDTC 08-14-2024
- Dividend Yield
- EDSA N/A
- LDTC N/A
- EPS Growth
- EDSA N/A
- LDTC N/A
- EPS
- EDSA N/A
- LDTC N/A
- Revenue
- EDSA N/A
- LDTC $6,052,694.00
- Revenue This Year
- EDSA N/A
- LDTC N/A
- Revenue Next Year
- EDSA N/A
- LDTC $2.28
- P/E Ratio
- EDSA N/A
- LDTC N/A
- Revenue Growth
- EDSA N/A
- LDTC 2.76
- 52 Week Low
- EDSA $2.09
- LDTC $0.22
- 52 Week High
- EDSA $6.46
- LDTC $11.20
- Technical
- Relative Strength Index (RSI)
- EDSA 19.32
- LDTC 59.16
- Support Level
- EDSA $2.26
- LDTC $0.28
- Resistance Level
- EDSA $2.44
- LDTC $0.35
- Average True Range (ATR)
- EDSA 0.26
- LDTC 0.04
- MACD
- EDSA -0.06
- LDTC 0.01
- Stochastic Oscillator
- EDSA 0.00
- LDTC 75.97
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis. The company operates in a single segment: research and development, manufacturing, and commercialization of innovative pharmaceutical products. The company's EB05 candidate is a monoclonal antibody therapy for hospitalized COVID-19 patients.
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation.